reference/14062930

Predicate	Object
contentType	Journal Article
endingPage	774
issn	0025-8105 1820-7383
issueIdentifier	11-12
pageRange	771-774
publicationName	Medical review
startingPage	771
bibliographicCitation	Konstantinidis G, Radovanov D, Konstantinidis N. Financial justification of investments into special diet for patients with phenylketonuria. Med pregl. 2010;63(11-12):771–4. doi: 10.2298/mpns1012771k.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e13850399dd17e1d6fa52ad74297e19b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5ccf531a8a211d1b952b7d106f21c8b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dffa96d326e70dabb47eacde42dc4c97
date	2010
identifier	https://pubmed.ncbi.nlm.nih.gov/21553452 https://doi.org/10.2298/mpns1012771k
isPartOf	https://portal.issn.org/resource/ISSN/1820-7383 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5650 https://portal.issn.org/resource/ISSN/0025-8105
language	Serbian\|English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Financial justification of investments into special diet for patients with phenylketonuria
discusses	http://id.nlm.nih.gov/mesh/M0029863
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10737 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8868 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab7136ba08704e4eb4a19169e1a26695

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459

Total number of triples: 31.